Real-time enrollment status for this cholangiocarcinoma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 12:19 AM UTC
| NCT Number | NCT05967182 |
| Recruiting Status | Recruiting |
| Condition | Cholangiocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | October 7, 2026 (1 week ago) |
As of October 17, 2026: Clinical trial NCT05967182 is currently recruiting participants. This phase2 study for cholangiocarcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05967182 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05967182 was last updated 1 week ago (October 7, 2026). HelloStudys verifies this status automatically.